GTBP Latest Press Releases

-- October 26, 2026 --

Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market Globe Newswire 9:00 AM

GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting Globe Newswire 8:00 AM

-- September 15, 2026 --

GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma Globe Newswire 9:15 AM

-- September 11, 2026 --

GT Biopharma to Host Live Company Presentation on the Development of TriKE Platform for Cancer Treatment, September 11, 2026 Globe Newswire 8:00 AM

-- August 14, 2026 --

GT Biopharma Reports Second Quarter 2026 Financial Results Globe Newswire 8:00 AM

-- July 6, 2026 --

A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs PRNewswire 11:20 AM

-- June 30, 2026 --

A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs PRNewswire 9:00 AM

-- June 12, 2026 --

After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell Globe Newswire 8:10 AM

-- June 8, 2026 --

Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet Globe Newswire 9:01 AM

-- June 1, 2026 --

GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes